Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,257,000 | 13,130,000 | 18,067,000 | 12,814,000 | 13,287,000 |
| Marketable Securities | 28,000 | 27,000 | 2,000 | 2,000 | 3,000 |
| Receivables | 11,472,000 | 11,724,000 | 11,949,000 | 11,155,000 | 11,412,000 |
| Inventories | 4,450,000 | 4,218,000 | 4,245,000 | 4,099,000 | 3,981,000 |
| TOTAL | $27,785,000 | $33,816,000 | $38,871,000 | $33,002,000 | $33,224,000 |
| Non-Current Assets | |||||
| PPE Net | 5,141,000 | 5,023,000 | 4,980,000 | 4,989,000 | 4,934,000 |
| Investments And Advances | 267,000 | 272,000 | 305,000 | 304,000 | 275,000 |
| Intangibles | 101,941,000 | 93,629,000 | 95,651,000 | 87,903,000 | 90,694,000 |
| Other Non-Current Assets | 8,288,000 | 9,197,000 | 9,067,000 | 8,513,000 | 7,094,000 |
| TOTAL | $115,637,000 | $108,121,000 | $110,003,000 | $101,709,000 | $102,997,000 |
| Total Assets | $143,422,000 | $141,937,000 | $148,874,000 | $134,711,000 | $136,221,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,570,000 | 12,586,000 | 10,196,000 | 7,191,000 | 5,115,000 |
| Accounts payable and accrued liabilities | 30,492,000 | 29,329,000 | 31,326,000 | 30,650,000 | 29,658,000 |
| TOTAL | $43,062,000 | $41,915,000 | $41,522,000 | $37,841,000 | $34,773,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,509,000 | 58,048,000 | 63,805,000 | 52,194,000 | 55,631,000 |
| Other Non-Current Liabilities | 33,028,000 | 32,424,000 | 32,775,000 | 32,325,000 | 31,641,000 |
| TOTAL | $94,289,000 | $93,201,000 | $99,305,000 | $86,473,000 | $89,319,000 |
| Total Liabilities | $137,351,000 | $135,116,000 | $140,827,000 | $124,314,000 | $124,092,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,767,140 | 1,766,344 | 1,765,868 | 1,766,473 | 1,765,537 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | -4,964,000 | -3,768,000 | -2,384,000 | -1,000,000 | 933,000 |
| Other shareholders' equity | -2,295,000 | -2,470,000 | -2,414,000 | -2,268,000 | -2,318,000 |
| TOTAL | $6,071,000 | $6,821,000 | $8,047,000 | $10,397,000 | $12,129,000 |
| Total Liabilities And Equity | $143,422,000 | $141,937,000 | $148,874,000 | $134,711,000 | $136,221,000 |